Tofacitinib in Patients with Ulcerative Colitis: Health-Related Quality of Life in Phase 3 Randomised Controlled Induction and Maintenance Studies-Reference-Cited by-同舟云学术

Tofacitinib in Patients with Ulcerative Colitis: Health-Related Quality of Life in Phase 3 Randomised Controlled Induction and Maintenance Studies

Published:2018-11-08 Issue:1 Volume:13 Page:139-140
ISSN:1873-9946
Container-title:Journal of Crohn's and Colitis
language:en
Short-container-title:

Author:

Panés Julian¹,Vermeire Séverine²,Lindsay James O³,Sands Bruce E⁴,Su Chinyu⁵,Friedman Gary⁵,Zhang Haiying⁵,Yarlas Aaron⁶,Bayliss Martha⁶,Maher Stephen⁶,Cappelleri Joseph C⁷,Bushmakin Andrew G⁷,Rubin David T⁸

Affiliation:

1. Hospital Clínic de Barcelona, IDIBAPS, CIBERehd, Barcelona, Spain

2. Department of Gastroenterology, University Hospitals Leuven, Leuven, Belgium

3. Centre for Immunobiology, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK

4. Dr Henry D. Janowitz Division of Gastroenterology, Icahn School of Medicine at Mount Sinai, New York, NY, USA

5. Pfizer Inc, Collegeville, PA, USA

6. Optum, Lincoln, RI, USA

7. Pfizer Inc, Groton, CT, USA

8. The University of Chicago Medicine, Inflammatory Bowel Disease Center, Chicago, IL, USA

Publisher

Oxford University Press (OUP)

Subject

Gastroenterology,General Medicine

Link

http://academic.oup.com/ecco-jcc/article-pdf/13/1/139/27235795/jjy135.pdf

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Aktualisierte S3-Leitlinie Colitis ulcerosa (Version 6.2);Zeitschrift für Gastroenterologie;2024-05

2. Aktualisierte S3-Leitlinie Colitis ulcerosa (Version 6.1) – Februar 2023 – AWMF-Registriernummer: 021-009;Zeitschrift für Gastroenterologie;2023-08

3. Matching-Adjusted Indirect Comparisons of Filgotinib vs Vedolizumab, Tofacitinib, and Ustekinumab for Moderately to Severely Active Ulcerative Colitis;Inflammatory Bowel Diseases;2023-03-22

4. Exploring the Pipeline of Novel Therapies for Inflammatory Bowel Disease; State of the Art Review;Biomedicines;2023-03-01

5. An Update on Current Pharmacotherapeutic Options for the Treatment of Ulcerative Colitis;Journal of Clinical Medicine;2022-04-20